Patient . | Age . | Sex . | Valve phenotype . | Valve function (≥ moderate) . | Maximal diameter of ascending aorta (mm) . | |
---|---|---|---|---|---|---|
AS . | AR . | |||||
1 | 46 | M | BAV | − | − | 42a |
2 | 59 | M | TAV | − | + | 47 |
3 | 58 | M | BAV | − | − | 49 |
4 | 79 | F | TAV | − | + | 63 |
5 | 64 | M | TAV | − | + | 36a |
Patient . | Age . | Sex . | Valve phenotype . | Valve function (≥ moderate) . | Maximal diameter of ascending aorta (mm) . | |
---|---|---|---|---|---|---|
AS . | AR . | |||||
1 | 46 | M | BAV | − | − | 42a |
2 | 59 | M | TAV | − | + | 47 |
3 | 58 | M | BAV | − | − | 49 |
4 | 79 | F | TAV | − | + | 63 |
5 | 64 | M | TAV | − | + | 36a |
AR: aortic valve regurgitation; AS: aortic valve stenosis; BAV: bicuspid aortic valve; F: female; M: male; TAV: tricuspid aortic valve.
Indication for surgery was aortic root aneurysm.
Patient . | Age . | Sex . | Valve phenotype . | Valve function (≥ moderate) . | Maximal diameter of ascending aorta (mm) . | |
---|---|---|---|---|---|---|
AS . | AR . | |||||
1 | 46 | M | BAV | − | − | 42a |
2 | 59 | M | TAV | − | + | 47 |
3 | 58 | M | BAV | − | − | 49 |
4 | 79 | F | TAV | − | + | 63 |
5 | 64 | M | TAV | − | + | 36a |
Patient . | Age . | Sex . | Valve phenotype . | Valve function (≥ moderate) . | Maximal diameter of ascending aorta (mm) . | |
---|---|---|---|---|---|---|
AS . | AR . | |||||
1 | 46 | M | BAV | − | − | 42a |
2 | 59 | M | TAV | − | + | 47 |
3 | 58 | M | BAV | − | − | 49 |
4 | 79 | F | TAV | − | + | 63 |
5 | 64 | M | TAV | − | + | 36a |
AR: aortic valve regurgitation; AS: aortic valve stenosis; BAV: bicuspid aortic valve; F: female; M: male; TAV: tricuspid aortic valve.
Indication for surgery was aortic root aneurysm.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.